Veli‐Matti Kähäri

19.7k total citations · 4 hit papers
217 papers, 16.1k citations indexed

About

Veli‐Matti Kähäri is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Veli‐Matti Kähäri has authored 217 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Cancer Research, 83 papers in Molecular Biology and 69 papers in Oncology. Recurrent topics in Veli‐Matti Kähäri's work include Protease and Inhibitor Mechanisms (70 papers), Cell Adhesion Molecules Research (45 papers) and Peptidase Inhibition and Analysis (40 papers). Veli‐Matti Kähäri is often cited by papers focused on Protease and Inhibitor Mechanisms (70 papers), Cell Adhesion Molecules Research (45 papers) and Peptidase Inhibition and Analysis (40 papers). Veli‐Matti Kähäri collaborates with scholars based in Finland, United States and United Kingdom. Veli‐Matti Kähäri's co-authors include Jukka Westermarck, Ulpu Saarialho‐Kere, Risto Ala‐aho, Pia Vihinen, Liisa Nissinen, Laura Ravanti, Jyrki Heino, Matti Ahonen, Reidar Grénman and Nina Johansson and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Veli‐Matti Kähäri

213 papers receiving 15.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of matrix metalloproteinase expression in tumor invasion

1999 1.3k citations Jukka Westermarck, Veli‐Matti Kähäri profile →
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets

2002 536 citations Pia Vihinen, Veli‐Matti Kähäri International Journal of Cancer profile →
CIP2A Inhibits PP2A in Human Malignancies

2007 533 citations Melissa R. Junttila, Minna Niemelä et al. profile →
Matrix metalloproteinases in skin

1997 503 citations Veli‐Matti Kähäri, Ulpu Saarialho‐Kere Experimental Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veli‐Matti Kähäri Finland	68	6.8k	6.1k	4.4k	2.3k	1.9k	217	16.1k
Lawrence F. Brown United States	75	13.7k 2.0×	5.2k 0.9×	6.1k 1.4×	2.0k 0.9×	1.8k 0.9×	111	23.2k
Jorma Keski‐Oja Finland	65	7.9k 1.2×	4.9k 0.8×	3.4k 0.8×	3.3k 1.4×	1.8k 0.9×	194	15.9k
Norbert E. Fusenig Germany	59	6.9k 1.0×	3.1k 0.5×	3.7k 0.9×	1.5k 0.7×	3.3k 1.8×	175	15.9k
Ulpu Saarialho‐Kere Finland	59	3.5k 0.5×	4.0k 0.7×	2.4k 0.6×	1.3k 0.6×	906 0.5×	141	10.8k
Howard G. Welgus United States	70	3.7k 0.5×	7.0k 1.2×	3.7k 0.9×	2.1k 0.9×	870 0.5×	130	14.3k
Constance Brinckerhoff United States	58	4.8k 0.7×	5.1k 0.8×	3.2k 0.7×	1.5k 0.7×	738 0.4×	151	11.3k
Donald R. Senger United States	54	11.3k 1.7×	4.4k 0.7×	3.3k 0.8×	2.3k 1.0×	1.5k 0.8×	89	18.7k
Lalage M. Wakefield United States	64	13.6k 2.0×	3.3k 0.5×	6.9k 1.6×	2.1k 0.9×	1.5k 0.8×	150	23.2k
J. Frederick Woessner United States	56	5.1k 0.7×	7.0k 1.2×	3.9k 0.9×	1.9k 0.8×	1.6k 0.9×	127	18.9k
Peter J. Polverini United States	66	9.9k 1.5×	3.8k 0.6×	6.1k 1.4×	2.7k 1.2×	1.6k 0.9×	146	20.4k

Countries citing papers authored by Veli‐Matti Kähäri

Since Specialization

Citations

This map shows the geographic impact of Veli‐Matti Kähäri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veli‐Matti Kähäri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veli‐Matti Kähäri more than expected).

Fields of papers citing papers by Veli‐Matti Kähäri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veli‐Matti Kähäri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veli‐Matti Kähäri. The network helps show where Veli‐Matti Kähäri may publish in the future.

Co-authorship network of co-authors of Veli‐Matti Kähäri

This figure shows the co-authorship network connecting the top 25 collaborators of Veli‐Matti Kähäri. A scholar is included among the top collaborators of Veli‐Matti Kähäri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veli‐Matti Kähäri. Veli‐Matti Kähäri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nissinen, Liisa, Elina Siljamäki, Pekka Rappu, et al.. (2025). Expression of C1q by Macrophages and Fibroblasts in Tumor Microenvironment Is Associated with Progression and Metastasis of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 145(11). 2854–2868.e4. 2 indexed citations

Jokilammi, Anne, Pia Rantakari, Pauliina Kronqvist, et al.. (2024). Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo. ChemBioChem. 25(18). e202400264–e202400264. 1 indexed citations

Nissinen, Liisa, et al.. (2024). Clustering of RNA co-expression network identifies novel long non-coding RNA biomarkers in squamous cell carcinoma. Scientific Reports. 14(1). 16864–16864. 2 indexed citations

Riihilä, Pilvi, Sirkku Peltonen, Markku Kallajoki, et al.. (2022). Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. Cancers. 14(2). 305–305. 14 indexed citations

Riihilä, Pilvi, Minna Piipponen, Markku Kallajoki, et al.. (2021). Complement factor I upregulates expression of matrix metalloproteinase‐13 and ‐2 and promotes invasion of cutaneous squamous carcinoma cells. Experimental Dermatology. 30(11). 1631–1641. 19 indexed citations

Riihilä, Pilvi, Liisa Nissinen, & Veli‐Matti Kähäri. (2020). Matrix metalloproteinases in keratinocyte carcinomas. Experimental Dermatology. 30(1). 50–61. 31 indexed citations

Laine, Anni, Harri Sihto, Christophé Côme, et al.. (2013). Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1. Cancer Discovery. 3(2). 182–197. 101 indexed citations

Heikkinen, Pekka T., et al.. (2010). Hypoxic Conversion of SMAD7 Function from an Inhibitor into a Promoter of Cell Invasion. Cancer Research. 70(14). 5984–5993. 28 indexed citations

Klemi, Pekka, Ilmo Leivo, Antti Mäkitie, et al.. (2009). Expression of matrix metalloproteinase‐1, ‐7, ‐9, ‐13, Ki‐67, and HER‐2 in epithelial‐myoepithelial salivary gland cancer. Head & Neck. 32(8). 1019–1027. 18 indexed citations

10.

Sebe, Attila, Suvi‐Katri Leivonen, Attila Fintha, et al.. (2008). Transforming growth factor- -induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38 mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation. Nephrology Dialysis Transplantation. 23(5). 1537–1545. 54 indexed citations

11.

Vähä‐Koskela, Markus, Jari Heikkilä, Valeri Zakhartchenko, et al.. (2006). Oncolytic Capacity of Attenuated Replicative Semliki Forest Virus in Human Melanoma Xenografts in Severe Combined Immunodeficient Mice. Cancer Research. 66(14). 7185–7194. 55 indexed citations

12.

Kivisaari, Atte, Markku Kallajoki, John A. McGrath, et al.. (2006). Spatial expression of matrilysin-1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas. Journal of Investigative Dermatology. 126. 23–23. 4 indexed citations

13.

Vihinen, Pia, et al.. (2006). Serum VEGF-C is associated with metastatic site in patients with malignant melanoma. Acta Oncologica. 46(5). 678–684. 24 indexed citations

14.

Impola, Ulla, Mervi Toriseva, Sari Suomela, et al.. (2002). Matrix metalloproteinase‐19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. International Journal of Cancer. 103(6). 709–716. 54 indexed citations

15.

Ala‐aho, Risto, Reidar Grénman, Prem Seth, & Veli‐Matti Kähäri. (2002). Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene. 21(8). 1187–1195. 59 indexed citations

16.

Kerkelä, Erja, Risto Ala‐aho, Leila Jeskanen, et al.. (2000). Expression of Human Macrophage Metalloelastase (MMP-12) by Tumor Cells in Skin Cancer. Journal of Investigative Dermatology. 114(6). 1113–1119. 82 indexed citations

17.

Airola, Kristiina, Matti Ahonen, Nina Johansson, et al.. (1998). Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. European Journal of Histochemistry. 1998(46). 437–447. 8 indexed citations

18.

Airola, Kristiina, Nina Johansson, Arja‐Leena Kariniemi, Veli‐Matti Kähäri, & Ulpu Saarialho‐Kere. (1997). Human Collagenase-3 Is Expressed in Malignant Squamous Epithelium of the Skin. Journal of Investigative Dermatology. 109(2). 225–231. 152 indexed citations

19.

Kähäri, Veli‐Matti & Ulpu Saarialho‐Kere. (1997). Matrix metalloproteinases in skin. Experimental Dermatology. 6(5). 199–213. 503 indexed citations breakdown →

20.

Rosenbloom, Joel, Joel Rosenbloom, Muhammad M. Bashir, et al.. (1991). Regulation of Elastin Gene Expression^a. Annals of the New York Academy of Sciences. 624(1). 116–136. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact